{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:01:23Z","timestamp":1791489683292,"version":"4.3.4"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,9,11]],"date-time":"2015-09-11T00:00:00Z","timestamp":1441929600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12876-015-0346-7","type":"journal-article","created":{"date-parts":[[2015,9,11]],"date-time":"2015-09-11T13:19:39Z","timestamp":1441977579000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Effects of acotiamide on esophageal motor function and gastroesophageal reflux in healthy volunteers"],"prefix":"10.1186","volume":"15","author":[{"given":"Norihisa","family":"Ishimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mami","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironobu","family":"Mikami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shino","family":"Shimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goichi","family":"Uno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahito","family":"Aimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Oshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunji","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikazu","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,11]]},"reference":[{"issue":"6","key":"346_CR1","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1136\/gutjnl-2012-304269","volume":"63","author":"HB El-Serag","year":"2014","unstructured":"El-Serag HB, Sweet S, Winchester CC, Dent J. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2014;63(6):871\u201380.","journal-title":"Gut"},{"issue":"10","key":"346_CR2","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1136\/gutjnl-2011-300715","volume":"61","author":"E Ness-Jensen","year":"2012","unstructured":"Ness-Jensen E, Lindam A, Lagergren J, Hveem K. Changes in prevalence, incidence and spontaneous loss of gastro-oesophageal reflux symptoms: a prospective population-based cohort study, the HUNT study. Gut. 2012;61(10):1390\u20137.","journal-title":"Gut"},{"issue":"9","key":"346_CR3","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1007\/s00535-011-0429-3","volume":"46","author":"Y Kinoshita","year":"2011","unstructured":"Kinoshita Y, Adachi K, Hongo M, Haruma K. Systematic review of the epidemiology of gastroesophageal reflux disease in Japan. J Gastroenterol. 2011;46(9):1092\u2013103.","journal-title":"J Gastroenterol"},{"key":"346_CR4","doi-asserted-by":"crossref","unstructured":"Okimoto E, Ishimura N, Morito Y, Mikami H, Shimura S, Uno G, et al. Prevalence of gastroesophageal reflux disease in children, adults, and elderly in same community. J Gastroenterol Hepatol. 2015;30(7):1140\u20136.","DOI":"10.1111\/jgh.12899"},{"issue":"4","key":"346_CR5","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/gut.41.4.452","volume":"41","author":"Y Kinoshita","year":"1997","unstructured":"Kinoshita Y, Kawanami C, Kishi K, Nakata H, Seino Y, Chiba T. Helicobacter pylori independent chronological change in gastric acid secretion in the Japanese. Gut. 1997;41(4):452\u20138.","journal-title":"Gut"},{"issue":"Suppl 4","key":"346_CR6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/jgh.12238","volume":"28","author":"B Matsuura","year":"2013","unstructured":"Matsuura B, Nunoi H, Miyake T, Hiasa Y, Onji M. Obesity and gastrointestinal liver disorders in Japan. J Gastroenterol Hepatol. 2013;28 Suppl 4:48\u201353.","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"346_CR7","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00535-012-0671-3","volume":"48","author":"M Niigaki","year":"2013","unstructured":"Niigaki M, Adachi K, Hirakawa K, Furuta K, Kinoshita Y. Association between metabolic syndrome and prevalence of gastroesophageal reflux disease in a health screening facility in Japan. J Gastroenterol. 2013;48(4):463\u201372.","journal-title":"J Gastroenterol"},{"issue":"1","key":"346_CR8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1586\/egh.12.67","volume":"7","author":"S Shiota","year":"2013","unstructured":"Shiota S, Murakawi K, Suzuki R, Fujioka T, Yamaoka Y. Helicobacter pylori infection in Japan. Expert Rev Gastroenterol Hepatol. 2013;7(1):35\u201340.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"6","key":"346_CR9","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/nmo.12319","volume":"26","author":"H Suzuki","year":"2014","unstructured":"Suzuki H, Matsuzaki J, Masaoka T, Inadomi JM. Greater loss of productivity among Japanese workers with gastro-esophageal reflux disease (GERD) symptoms that persist vs resolve on medical therapy. Neurogastroenterol Motil. 2014;26(6):764\u201371.","journal-title":"Neurogastroenterol Motil"},{"issue":"10","key":"346_CR10","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1111\/j.1365-2036.2010.04471.x","volume":"32","author":"JH Rubenstein","year":"2010","unstructured":"Rubenstein JH, Taylor JB. Meta-analysis: the association of oesophageal adenocarcinoma with symptoms of gastro-oesophageal reflux. Aliment Pharmacol Ther. 2010;32(10):1222\u20137.","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"346_CR11","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/ajg.2011.153","volume":"106","author":"M Sikkema","year":"2011","unstructured":"Sikkema M, Looman CW, Steyerberg EW, Kerkhof M, Kastelein F, van Dekken H, et al. Predictors for neoplastic progression in patients with Barrett\u2019s Esophagus: a prospective cohort study. Am J Gastroenterol. 2011;106(7):1231\u20138.","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"346_CR12","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1136\/gutjnl-2012-302412","volume":"62","author":"G Edgren","year":"2013","unstructured":"Edgren G, Adami HO, Weiderpass E, Nyren O. A global assessment of the oesophageal adenocarcinoma epidemic. Gut. 2013;62(10):1406\u201314.","journal-title":"Gut"},{"issue":"3","key":"346_CR13","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ajg.2012.444","volume":"108","author":"PO Katz","year":"2013","unstructured":"Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013;108(3):308\u201328.","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"346_CR14","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1111\/jgh.12655","volume":"29","author":"KL Goh","year":"2014","unstructured":"Goh KL, Choi MG, Hsu WP, Chun HJ, Mahachai V, Kachintorn U, et al. Unmet treatment needs of gastroesophageal reflux disease in Asia: gastroesophageal reflux disease in Asia Pacific Survey. J Gastroenterol Hepatol. 2014;29(12):1969\u201375.","journal-title":"J Gastroenterol Hepatol"},{"issue":"9","key":"346_CR15","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/gutjnl-2011-301897","volume":"61","author":"D Sifrim","year":"2012","unstructured":"Sifrim D, Zerbib F. Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors. Gut. 2012;61(9):1340\u201354.","journal-title":"Gut"},{"issue":"Suppl 3","key":"346_CR16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1440-1746.2012.07064.x","volume":"27","author":"R Fass","year":"2012","unstructured":"Fass R. Therapeutic options for refractory gastroesophageal reflux disease. J Gastroenterol Hepatol. 2012;27 Suppl 3:3\u20137.","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"346_CR17","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5056\/jnm.2014.20.1.6","volume":"20","author":"C Maradey-Romero","year":"2014","unstructured":"Maradey-Romero C, Fass R. New and future drug development for gastroesophageal reflux disease. J Neurogastroenterol Motil. 2014;20(1):6\u201316.","journal-title":"J Neurogastroenterol Motil"},{"issue":"4","key":"346_CR18","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s10620-012-2430-y","volume":"58","author":"YK Cho","year":"2013","unstructured":"Cho YK, Choi MG, Park EY, Lim CH, Kim JS, Park JM, et al. Effect of mosapride combined with esomeprazole improves esophageal peristaltic function in patients with gastroesophageal reflux disease: a study using high resolution manometry. Dig Dis Sci. 2013;58(4):1035\u201341.","journal-title":"Dig Dis Sci"},{"issue":"9","key":"346_CR19","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.3748\/wjg.v20.i9.2412","volume":"20","author":"LH Ren","year":"2014","unstructured":"Ren LH, Chen WX, Qian LJ, Li S, Gu M, Shi RH. Addition of prokinetics to PPI therapy in gastroesophageal reflux disease: a meta-analysis. World J Gastroenterol. 2014;20(9):2412\u20139.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"346_CR20","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/j.1440-1746.2010.06280.x","volume":"25","author":"K Koshino","year":"2010","unstructured":"Koshino K, Adachi K, Furuta K, Ohara S, Morita T, Nakata S, et al. Effects of mosapride on esophageal functions and gastroesophageal reflux. J Gastroenterol Hepatol. 2010;25(6):1066\u201371.","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"346_CR21","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1136\/gutjnl-2011-301454","volume":"61","author":"K Matsueda","year":"2012","unstructured":"Matsueda K, Hongo M, Tack J, Saito Y, Kato H. A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia. Gut. 2012;61(6):821\u20138.","journal-title":"Gut"},{"issue":"4","key":"346_CR22","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000332404","volume":"84","author":"K Matsueda","year":"2011","unstructured":"Matsueda K, Hongo M, Ushijima S, Akiho H. A long-term study of acotiamide in patients with functional dyspepsia: results from an open-label phase III trial in Japan on efficacy, safety and pattern of administration. Digestion. 2011;84(4):261\u20138.","journal-title":"Digestion"},{"issue":"6","key":"346_CR23","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1365-2982.2012.01897.x","volume":"24","author":"H Kusunoki","year":"2012","unstructured":"Kusunoki H, Haruma K, Manabe N, Imamura H, Kamada T, Shiotani A, et al. Therapeutic efficacy of acotiamide in patients with functional dyspepsia based on enhanced postprandial gastric accommodation and emptying: randomized controlled study evaluation by real-time ultrasonography. Neurogastroenterol Motil. 2012;24(6):540\u20135. e250-541.","journal-title":"Neurogastroenterol Motil"},{"issue":"6","key":"346_CR24","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1365-2982.2012.01912.x","volume":"24","author":"K Nagahama","year":"2012","unstructured":"Nagahama K, Matsunaga Y, Kawachi M, Ito K, Tanaka T, Hori Y, et al. Acotiamide, a new orally active acetylcholinesterase inhibitor, stimulates gastrointestinal motor activity in conscious dogs. Neurogastroenterol Motil. 2012;24(6):566\u201374. e256.","journal-title":"Neurogastroenterol Motil"},{"issue":"5","key":"346_CR25","doi-asserted-by":"crossref","first-page":"G1033","DOI":"10.1152\/ajpgi.00444.2005","volume":"290","author":"JE Pandolfino","year":"2006","unstructured":"Pandolfino JE, Ghosh SK, Zhang Q, Jarosz A, Shah N, Kahrilas PJ. Quantifying EGJ morphology and relaxation with high-resolution manometry: a study of 75 asymptomatic volunteers. Am J Physiol Gastrointest Liver Physiol. 2006;290(5):G1033\u20131040.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"12","key":"346_CR26","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s40265-013-0100-9","volume":"73","author":"ML Nolan","year":"2013","unstructured":"Nolan ML, Scott LJ. Acotiamide: first global approval. Drugs. 2013;73(12):1377\u201383.","journal-title":"Drugs"},{"issue":"4 Pt 1","key":"346_CR27","first-page":"G677","volume":"261","author":"RE Clouse","year":"1991","unstructured":"Clouse RE, Staiano A. Topography of the esophageal peristaltic pressure wave. Am J Physiol. 1991;261(4 Pt 1):G677\u2013684.","journal-title":"Am J Physiol"},{"issue":"6 Pt 1","key":"346_CR28","first-page":"G1098","volume":"265","author":"RE Clouse","year":"1993","unstructured":"Clouse RE, Staiano A. Topography of normal and high-amplitude esophageal peristalsis. Am J Physiol. 1993;265(6 Pt 1):G1098\u20131107.","journal-title":"Am J Physiol"},{"issue":"7","key":"346_CR29","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1365-2982.2008.01129.x","volume":"20","author":"SK Ghosh","year":"2008","unstructured":"Ghosh SK, Janiak P, Fox M, Schwizer W, Hebbard GS, Brasseur JG. Physiology of the oesophageal transition zone in the presence of chronic bolus retention: studies using concurrent high resolution manometry and digital fluoroscopy. Neurogastroenterol Motil. 2008;20(7):750\u20139.","journal-title":"Neurogastroenterol Motil"},{"issue":"Suppl 1","key":"346_CR30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-2982.2011.01834.x","volume":"24","author":"AJ Bredenoord","year":"2012","unstructured":"Bredenoord AJ, Fox M, Kahrilas PJ, Pandolfino JE, Schwizer W, Smout AJ. Chicago classification criteria of esophageal motility disorders defined in high resolution esophageal pressure topography. Neurogastroenterol Motil. 2012;24 Suppl 1:57\u201365.","journal-title":"Neurogastroenterol Motil"},{"issue":"2","key":"346_CR31","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/nmo.12477","volume":"27","author":"PJ Kahrilas","year":"2015","unstructured":"Kahrilas PJ, Bredenoord AJ, Fox M, Gyawali CP, Roman S, Smout AJ, et al. The Chicago classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil. 2015;27(2):160\u201374.","journal-title":"Neurogastroenterol Motil"},{"issue":"6","key":"346_CR32","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1053\/gast.1996.1101982","volume":"110","author":"PJ Kahrilas","year":"1996","unstructured":"Kahrilas PJ, Quigley EM. Clinical esophageal pH recording: a technical review for practice guideline development. Gastroenterology. 1996;110(6):1982\u201396.","journal-title":"Gastroenterology"},{"issue":"6","key":"346_CR33","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.clnu.2009.05.006","volume":"28","author":"K Adachi","year":"2009","unstructured":"Adachi K, Furuta K, Morita T, Nakata S, Ohara S, Tanimura T, et al. Half-solidification of nutrient does not decrease gastro-esophageal reflux events in patients fed via percutaneous endoscopic gastrostomy. Clin Nutr. 2009;28(6):648\u201351.","journal-title":"Clin Nutr"},{"issue":"10","key":"346_CR34","doi-asserted-by":"crossref","first-page":"e509","DOI":"10.1111\/j.1365-2982.2012.02001.x","volume":"24","author":"Y Xiao","year":"2012","unstructured":"Xiao Y, Read A, Nicodeme F, Roman S, Kahrilas PJ, Pandolfino JE. The effect of a sitting vs supine posture on normative esophageal pressure topography metrics and Chicago classification diagnosis of esophageal motility disorders. Neurogastroenterol Motil. 2012;24(10):e509\u2013516.","journal-title":"Neurogastroenterol Motil"},{"issue":"18","key":"346_CR35","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.2165\/11597300-000000000-00000","volume":"71","author":"T Hershcovici","year":"2011","unstructured":"Hershcovici T, Fass R. Gastro-oesophageal reflux disease: beyond proton pump inhibitor therapy. Drugs. 2011;71(18):2381\u20139.","journal-title":"Drugs"},{"issue":"4","key":"346_CR36","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s10388-011-0289-1","volume":"8","author":"K Koshino","year":"2011","unstructured":"Koshino K, Adachi K, Furuta K, Aimi M, Fukazawa K, Shimura S, et al. Effects of nizatidine and itopride hydrochloride on esophageal motor function. Esophagus. 2011;8(4):253\u20137.","journal-title":"Esophagus"},{"issue":"2","key":"346_CR37","doi-asserted-by":"crossref","first-page":"181","DOI":"10.5056\/jnm.2012.18.2.181","volume":"18","author":"T Morita","year":"2012","unstructured":"Morita T, Furuta K, Adachi K, Ohara S, Tanimura T, Koshino K, et al. Effects of Rikkunshito (TJ-43) on esophageal motor function and gastroesophageal reflux. J Neurogastroenterol Motil. 2012;18(2):181\u20136.","journal-title":"J Neurogastroenterol Motil"},{"issue":"4","key":"346_CR38","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/01.mcg.0000210103.82241.97","volume":"40","author":"YK Cho","year":"2006","unstructured":"Cho YK, Choi MG, Han HW, Park JM, Oh JH, Jeong JJ, et al. The effect of mosapride on esophageal motility and bolus transit in asymptomatic volunteers. J Clin Gastroenterol. 2006;40(4):286\u201392.","journal-title":"J Clin Gastroenterol"},{"issue":"9","key":"346_CR39","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1007\/s00535-013-0876-0","volume":"49","author":"K Fukazawa","year":"2013","unstructured":"Fukazawa K, Furuta K, Adachi K, Moritou Y, Saito T, Kusunoki R, et al. Effects of mosapride on esophageal motor activity and esophagogastric junction compliance in healthy volunteers. J Gastroenterol. 2013;49(9):1307\u201313.","journal-title":"J Gastroenterol"},{"issue":"10","key":"346_CR40","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1097\/00042737-200310000-00009","volume":"15","author":"M Ruth","year":"2003","unstructured":"Ruth M, Finizia C, Cange L, Lundell L. The effect of mosapride on oesophageal motor function and acid reflux in patients with gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol. 2003;15(10):1115\u201321.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"346_CR41","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1046\/j.1365-2036.1998.00268.x","volume":"12","author":"M Ruth","year":"1998","unstructured":"Ruth M, Hamelin B, Rohss K, Lundell L. The effect of mosapride, a novel prokinetic, on acid reflux variables in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 1998;12(1):35\u201340.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1\u20133","key":"346_CR42","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ejphar.2011.05.049","volume":"666","author":"M Kawachi","year":"2011","unstructured":"Kawachi M, Matsunaga Y, Tanaka T, Hori Y, Ito K, Nagahama K, et al. Acotiamide hydrochloride (Z-338) enhances gastric motility and emptying by inhibiting acetylcholinesterase activity in rats. Eur J Pharmacol. 2011;666(1\u20133):218\u201325.","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"346_CR43","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1124\/jpet.110.174847","volume":"336","author":"Y Matsunaga","year":"2011","unstructured":"Matsunaga Y, Tanaka T, Yoshinaga K, Ueki S, Hori Y, Eta R, et al. Acotiamide hydrochloride (Z-338), a new selective acetylcholinesterase inhibitor, enhances gastric motility without prolonging QT interval in dogs: comparison with cisapride, itopride, and mosapride. J Pharmacol Exp Ther. 2011;336(3):791\u2013800.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"346_CR44","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0022-3565(24)39036-6","volume":"294","author":"M Ogishima","year":"2000","unstructured":"Ogishima M, Kaibara M, Ueki S, Kurimoto T, Taniyama K. Z-338 facilitates acetylcholine release from enteric neurons due to blockade of muscarinic autoreceptors in guinea pig stomach. J Pharmacol Exp Ther. 2000;294(1):33\u20137.","journal-title":"J Pharmacol Exp Ther"},{"issue":"11","key":"346_CR45","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1002\/jps.22649","volume":"100","author":"K Yoshii","year":"2011","unstructured":"Yoshii K, Hirayama M, Nakamura T, Toda R, Hasegawa J, Takei M, et al. Mechanism for distribution of acotiamide, a novel gastroprokinetic agent for the treatment of functional dyspepsia, in rat stomach. J Pharm Sci. 2011;100(11):4965\u201373.","journal-title":"J Pharm Sci"},{"issue":"6","key":"346_CR46","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1365-2982.2009.01449.x","volume":"22","author":"K Matsueda","year":"2010","unstructured":"Matsueda K, Hongo M, Tack J, Aoki H, Saito Y, Kato H. Clinical trial: dose-dependent therapeutic efficacy of acotiamide hydrochloride (Z-338) in patients with functional dyspepsia - 100\u00a0mg\u00a0t.i.d. is an optimal dosage. Neurogastroenterol Motil. 2010;22(6):618\u2013e173.","journal-title":"Neurogastroenterol Motil"},{"issue":"3","key":"346_CR47","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1365-2982.2009.01261.x","volume":"21","author":"J Tack","year":"2009","unstructured":"Tack J, Masclee A, Heading R, Berstad A, Piessevaux H, Popiela T, et al. A dose-ranging, placebo-controlled, pilot trial of Acotiamide in patients with functional dyspepsia. Neurogastroenterol Motil. 2009;21(3):272\u201380.","journal-title":"Neurogastroenterol Motil"},{"issue":"3","key":"346_CR48","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/nmo.12513","volume":"27","author":"C Almansa","year":"2015","unstructured":"Almansa C, Smith JA, Morris J, Crowell MD, Valdramidou D, Lee AS, et al. Weak peristalsis with large breaks in chronic cough: association with poor esophageal clearance. Neurogastroenterol Motil. 2015;27(3):431\u201342.","journal-title":"Neurogastroenterol Motil"},{"issue":"1","key":"346_CR49","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/ajg.2013.373","volume":"109","author":"M Ribolsi","year":"2014","unstructured":"Ribolsi M, Balestrieri P, Emerenziani S, Guarino MP, Cicala M. Weak peristalsis with large breaks is associated with higher acid exposure and delayed reflux clearance in the supine position in GERD patients. Am J Gastroenterol. 2014;109(1):46\u201351.","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"346_CR50","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/nmo.12359","volume":"26","author":"BF Kessing","year":"2014","unstructured":"Kessing BF, Smout AJ, Bennink RJ, Kraaijpoel N, Oors JM, Bredenoord AJ. Prucalopride decreases esophageal acid exposure and accelerates gastric emptying in healthy subjects. Neurogastroenterol Motil. 2014;26(8):1079\u201386.","journal-title":"Neurogastroenterol Motil"},{"issue":"5","key":"346_CR51","first-page":"A535","volume":"136","author":"B Adam","year":"2009","unstructured":"Adam B, Liebregts T, Zschau NB, Faraguna LA, Gapasin JD, Andrews JM, et al. Z-338 improves meal-induced symptoms in functional dyspepsia: a double-blind, randomized. Placebo controlled crossover study. Gastroenterology. 2009;136(5):A535\u20135.","journal-title":"Gastroenterology"},{"issue":"9","key":"346_CR52","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1365-2982.2008.01135.x","volume":"20","author":"K Seto","year":"2008","unstructured":"Seto K, Sasaki T, Katsunuma K, Kobayashi N, Tanaka K, Tack J. Acotiamide hydrochloride (Z-338), a novel prokinetic agent, restores delayed gastric emptying and feeding inhibition induced by restraint stress in rats. Neurogastroenterol Motil. 2008;20(9):1051\u20139.","journal-title":"Neurogastroenterol Motil"},{"issue":"12","key":"346_CR53","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/eci.12367","volume":"44","author":"H Zai","year":"2014","unstructured":"Zai H, Matsueda K, Kusano M, Urita Y, Saito Y, Kato H. Effect of acotiamide on gastric emptying in healthy adult humans. Eur J Clin Invest. 2014;44(12):1215\u201321.","journal-title":"Eur J Clin Invest"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-015-0346-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12876-015-0346-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-015-0346-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T15:42:46Z","timestamp":1748619766000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-015-0346-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,11]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["346"],"URL":"https:\/\/doi.org\/10.1186\/s12876-015-0346-7","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,11]]},"article-number":"117"}}